0000905148-21-000431.txt : 20210505 0000905148-21-000431.hdr.sgml : 20210505 20210505181848 ACCESSION NUMBER: 0000905148-21-000431 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazquez Martin CENTRAL INDEX KEY: 0001823380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 21894993 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 form4.xml X0306 4 2021-05-03 0001484612 Outset Medical, Inc. OM 0001823380 Vazquez Martin 3052 ORCHARD DRIVE SAN JOSE CA 95134 true Chief Operating Officer Common Stock 2021-05-03 4 M 0 2932 3.88 A 12187 D Common Stock 2021-05-03 4 M 0 2068 3.88 A 14255 D Common Stock 2021-05-03 4 S 0 4224 57.8896 D 10031 D Common Stock 2021-05-03 4 S 0 539 58.8242 D 9492 D Common Stock 2021-05-03 4 S 0 237 59.8059 D 9255 D Performance Stock Option (Right to Buy) 3.88 2021-05-03 4 M 0 2932 0 D 2018-12-21 2027-12-19 Common Stock 2932 0 D Stock Option (Right to Buy) 3.88 2021-05-03 4 M 0 2068 0 D 2027-12-19 Common Stock 2068 89489 D The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $57.46 to $58.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $58.48 to $58.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $59.77 to $60.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. This option vests 25% on October 9, 2018 and then in 36 monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting period. /s/ John L. Brottem, attorney-in-fact for Martin Vazquez 2021-05-05